Rocket Lab's Defense Growth Masks Neutron Risks in Strong Q4
Read source articleWhat happened
Rocket Lab reported robust Q4 2025 results with $180M revenue, up 36% year-over-year, and record 38% GAAP gross margins, while full-year revenue reached $602M. Backlog expanded to $1.85B, with 37% expected to convert within 12 months, implying about $685M in near-term revenue visibility before new contracts. Space Systems and defense programs, including over $1.3B in SDA contracts for missile-tracking satellites, are driving this growth, as highlighted in a Seeking Alpha article. The DeepValue master report corroborates this shift, noting that Neutron development remains risky and cash-intensive, with its first launch now targeted for Q4 2026 after prior delays. Despite positive top-line momentum, the company continues to burn cash with negative profitability, emphasizing the need for execution on defense milestones rather than relying on Neutron for near-term value.
Implication
The strong Q4 results and backlog growth validate the shift towards Space Systems as Rocket Lab's primary growth engine, reducing reliance on Neutron in the near term. However, the SDA contracts target FY2029 launches, meaning revenue recognition is back-end loaded, requiring careful monitoring of milestone billing in 2026-2027. Neutron's development risks, including potential qualification failures, could trigger further dilution and sentiment declines if timelines slip again. Current cash-burning fundamentals and high valuation multiples demand smaller position sizes and milestone-based adds, not a buy-and-hold approach. Ultimately, the stock's upside hinges on Electron cadence sustaining revenue while defense programs deliver tangible economic impact ahead of Neutron's debut.
Thesis delta
The article reinforces the DeepValue report's thesis that Rocket Lab's growth is increasingly tied to Space Systems and defense contracts, not Neutron, confirming a narrative shift already priced in. This emphasizes the critical need for execution on SDA milestone billing and Electron reliability to offset Neutron's risks and cash burn. No fundamental change to the thesis occurs, but it underscores that near-term investor focus should remain on defense ramp transparency and qualification progress.
Confidence
high